Business Context and Reporting Period
Company: Synopsys, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended March 30, 1996 (Fiscal 1996 Q2).
Business Overview: Synopsys provides electronic design automation (EDA) software and systems. The company operates globally with significant international revenue exposure.
Key Financial Metrics
| Metric (in thousands) | Q2 1996 | Q2 1995 | 6 Months 1996 | 6 Months 1995 |
|---|---|---|---|---|
| Total Revenue | $85,000 | $64,000 | $164,000 | $123,900 |
| Gross Margin | $75,807 | $55,729 | $146,473 | $109,031 |
| Gross Margin % | 89.2% | 87.1% | 89.3% | 88.0% |
| Operating Income (Loss) | $(23,400) | $12,100 | $(7,600) | $23,800 |
| Net Income (Loss) | $(14,300) | $8,318 | $(2,650) | $16,124 |
| Diluted EPS | $(0.36) | $0.21 | $(0.07) | $0.41 |
| Cash & Short-term Investments | $225,375 | $209,984 | $225,375 | $209,984 |
| Long-term Debt | $19,625 | $0 | $19,625 | $0 |
| Current Portion of Debt | $12,561 | $4,061 | $12,561 | $4,061 |
Cash Flow (6 Months): Net cash provided by operating activities was $39.3 million. Net cash used in investing activities was $46.5 million, driven by short-term investment changes and capital expenditures.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 33% year-over-year in Q2 and 32% for the six-month period, driven by increased worldwide licensing and sales of software and systems.
- Profitability Decline: The company reported a net loss of $14.3 million in Q2 compared to net income of $8.3 million in the prior year. This was primarily due to a one-time charge.
- IBM Transaction Impact: A $39.7 million charge for in-process research and development (IPR&D) was recorded in Q2 related to a joint development agreement with IBM. This charge significantly impacted operating and net income.
- Debt Increase: Long-term debt increased from $0 to $19.6 million, and current debt increased to $12.6 million, associated with the IBM agreement notes.
- Expense Increases: R&D expenses rose to $20.4 million (24% of revenue) from $13.5 million (21% of revenue) due to personnel increases. Sales and marketing expenses also increased in absolute dollars.
Guidance, Outlook, and Risks
- Outlook: Management believes existing cash ($225.4 million) and credit facilities are sufficient for the next 12 months. The book-to-bill ratio for Q2 was greater than 1.0.
- Strategic Initiatives:
- IBM Agreement: A six-year joint development and license agreement to co-develop EDA products (synthesis, test, design planning). Synopsys will own synthesis products exclusively.
- CCT Investment: Acquired ~9.9% of Cooper and Chyan Technology (CCT) for routing technology.
- Stock Repurchase: Authorized a program to repurchase up to 2.0 million shares (approx. 5% of outstanding) over 24 months.
- Risks and Contingencies:
- Market Competition: High competition in the EDA industry; potential pricing pressure.
- Semiconductor Cycle: Growth in the semiconductor industry has slowed, creating uncertainty for 1996.
- Product Development: Success depends on new products (Behavioral Compiler, Cell Based Array) gaining broad market acceptance.
- Operational Risks: Ongoing enterprise-wide database upgrade (SAP) carries implementation risks. Key personnel retention is critical.
- Seasonality: Orders are weighted toward the latter part of quarters and are seasonal (higher in Q2 and Q4).
Investor Verification Checklist
- IBM Deal Terms: Verify the specific milestones for the $30 million notes payable to IBM and the royalty structure for new products.
- Recurring Revenue Quality: Assess the sustainability of the 33% revenue growth excluding the impact of the IBM transaction and seasonal order patterns.
- Debt Service: Confirm the interest rate (3%) and maturity (2006) of the IBM notes and the impact on future cash flows.
- Stock Repurchase Execution: Monitor the pace of the authorized 2.0 million share buyback program.
- International Exposure: Evaluate the impact of foreign currency fluctuations (specifically the Yen) on future margins given 52% of Q2 revenue was international.